Skip to main content
OpenTrials
Completed

NCT Number: NCT04368338

Lung Ultrasound to Diagnose COVID-19

Covid-19 (English acronym meaning coronavirus disease 2019) is an emerging infectious disease caused by a strain of coronavirus called SARS-CoV-2. The current pandemic has resulted in a significant number of admissions in the emergency room (ER) due to suspicion of COVID-19 infection. Use of lung ultrasound is standard practice to diagnose acute respiratory failure in ER. Recently, typical lung ultrasonographic characteristics of COVID-19 disease has been described. During the COVID-19 pandemic, the use of this tool could be of interest in order to allow an early, simple and reliable triage in patients with suspected COVID-19 infection admitted in ER. In addition, the visualization of early signs in specific areas could be a predictive marker of the severity of the disease. The objective of this project will be to study the association between the signs on lung ultrasound and the result of RT-PCR in patients with suspected COVID-19 infection in the ER.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

COVID-19 Coronaviridae Infections Coronavirus Infections Infections Lung Diseases Lung Ultrasound Nidovirales Infections Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Complication Respiratory Tract Diseases Respiratory Tract Infections Virus Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

BAR

Amiens, 80054, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients admitted to Emergency Room for suspicion of COVID-19 infection with has a SARS-CoV-2 RT-PCR test and for whom the emergency doctor decide to perform a lung ultrasound

Exclusion criteria

  • patients < 18 years of age or under guardianship or curators,
  • pregnancy
  • poor echogenicity due to the presence of an acoustic barrier (pneumothorax, subcutaneous emphysema, etc.)
  • patients with a suspected or proven acute lung disease (pneumonitis, acute respiratory distress syndrome (ARDS))
  • chronic interstitial lung disease
  • patients who will refuse to give their consent.

Treatment and study plan

COVID-19 RT-PCR

Diagnostic Test

Polymerase chain reaction tests after reverse transcription for the detection of viral Covid-19 RNA (RT-PCR)

Lung ultrasound

Procedure

lung ultrasound is standard practice to diagnose acute respiratory failure in Emergency room

Primary outcomes

  1. Lung ultrasound/biological correlation research modulating the severity of Covid-19 disease

    Time frame: 6 months

    Polymerase chain reaction tests after reverse transcription for the detection of covid-19 viral RNA will be done as biological test.

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire, Amiens

Other

Registry information

Official study title

Use of Lung Ultrasound in Patients Suspected of COVID-19 Infection in the Emergency Room

Acronym: COVILUS

Important dates

Study start
2020
Primary completion
2021
Study completion
2021
First posted
Apr 29, 2020
Registry last updated
Jul 21, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.